Regulation of lipoprotein processing by GPNMB in foamy macrophages: potential therapeutic targets for atherosclerosis.

Saved in:
Bibliographic Details
Title: Regulation of lipoprotein processing by GPNMB in foamy macrophages: potential therapeutic targets for atherosclerosis.
Authors: Wang J; State Key Laboratory of Proteomics, National Center for Protein Sciences, Beijing, Beijing Proteome Research Center, Beijing Institute of Lifeomics, Beijing, PR China.; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, PR China.; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, PR China., Peng L; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, PR China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, PR China.; Department of Cardiology, Xiangya Hospital, Central South University, Changsha, Hunan, PR China., Wang H; State Key Laboratory of Proteomics, National Center for Protein Sciences, Beijing, Beijing Proteome Research Center, Beijing Institute of Lifeomics, Beijing, PR China., Liu D; State Key Laboratory of Proteomics, National Center for Protein Sciences, Beijing, Beijing Proteome Research Center, Beijing Institute of Lifeomics, Beijing, PR China., Yang W; State Key Laboratory of Proteomics, National Center for Protein Sciences, Beijing, Beijing Proteome Research Center, Beijing Institute of Lifeomics, Beijing, PR China., Yan F; State Key Laboratory of Proteomics, National Center for Protein Sciences, Beijing, Beijing Proteome Research Center, Beijing Institute of Lifeomics, Beijing, PR China., Zhao D; State Key Laboratory of Proteomics, National Center for Protein Sciences, Beijing, Beijing Proteome Research Center, Beijing Institute of Lifeomics, Beijing, PR China., Zhang C; State Key Laboratory of Proteomics, National Center for Protein Sciences, Beijing, Beijing Proteome Research Center, Beijing Institute of Lifeomics, Beijing, PR China., He Z; Guangzhou CSR Biotech Co. Ltd, Guangzhou, Guangdong, PR China., Chen XP; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, PR China. chenxiaoping@csu.edu.cn.; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, PR China. chenxiaoping@csu.edu.cn.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, PR China. chenxiaoping@csu.edu.cn.; FuRong Laboratory, Changsha, Hunan, China. chenxiaoping@csu.edu.cn., Tang L; State Key Laboratory of Proteomics, National Center for Protein Sciences, Beijing, Beijing Proteome Research Center, Beijing Institute of Lifeomics, Beijing, PR China. tangli731@163.com.; Institute of Future Agriculture, Northwest A&F University, Yangling, Shaanxi, PR China. tangli731@163.com.
Source: Nature communications [Nat Commun] 2025 Nov 14; Vol. 16 (1), pp. 10030. Date of Electronic Publication: 2025 Nov 14.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2041-1723
DOI:10.1038/s41467-025-65224-x